Bank Of New York Mellon Corp Summit Therapeutics Inc. Transaction History

Bank Of New York Mellon Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.68 - $5.31 $14,355 - $112,099	21,111 New	21,111 $89,000
Q2 2022 Aug 15, 2022	SELL	$0.92 - $2.38 $45,781 - $118,435	-49,763 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$2.45 - $5.64 $12,178 - $28,036	4,971 Added 11.1%	49,763 $134,000
Q3 2021 Nov 12, 2021	BUY	$4.83 - $8.27 $37,084 - $63,497	7,678 Added 20.69%	44,792 $224,000
Q2 2021 Aug 11, 2021	BUY	$5.15 - $8.46 $191,137 - $313,984	37,114 New	37,114 $276,000

193

75.8M

2.01M

2.84M

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $3.82B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.